HHS Public Access Author Manuscript
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Classification of Esterases: an Important Gene Family Involved in Insecticide Resistance - a Review
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(4): 437-449, June 2012 437 The classification of esterases: an important gene family involved in insecticide resistance - A Review Isabela Reis Montella1,2, Renata Schama1,2,3/+, Denise Valle1,2,3 1Laboratório de Fisiologia e Controle de Artrópodes Vetores, Instituto Oswaldo Cruz-Fiocruz, Av. Brasil 4365, 21040-900 Rio de Janeiro, RJ, Brasil 2Instituto de Biologia do Exército, Rio de Janeiro, RJ, Brasil 3Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular, Rio de Janeiro, RJ, Brasil The use of chemical insecticides continues to play a major role in the control of disease vector populations, which is leading to the global dissemination of insecticide resistance. A greater capacity to detoxify insecticides, due to an increase in the expression or activity of three major enzyme families, also known as metabolic resistance, is one major resistance mechanisms. The esterase family of enzymes hydrolyse ester bonds, which are present in a wide range of insecticides; therefore, these enzymes may be involved in resistance to the main chemicals employed in control programs. Historically, insecticide resistance has driven research on insect esterases and schemes for their classification. Currently, several different nomenclatures are used to describe the esterases of distinct species and a universal standard classification does not exist. The esterase gene family appears to be rapidly evolving and each insect species has a unique complement of detoxification genes with only a few orthologues across species. The examples listed in this review cover different aspects of their biochemical nature. However, they do not appear to contribute to reliably distinguish among the different resistance mechanisms. -
The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
cancers Review The Mutational Landscape of Myeloid Leukaemia in Down Syndrome Carini Picardi Morais de Castro 1, Maria Cadefau 1,2 and Sergi Cuartero 1,2,* 1 Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, 08916 Badalona, Spain; [email protected] (C.P.M.d.C); [email protected] (M.C.) 2 Germans Trias i Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain * Correspondence: [email protected] Simple Summary: Leukaemia occurs when specific mutations promote aberrant transcriptional and proliferation programs, which drive uncontrolled cell division and inhibit the cell’s capacity to differentiate. In this review, we summarize the most frequent genetic lesions found in myeloid leukaemia of Down syndrome, a rare paediatric leukaemia specific to individuals with trisomy 21. The evolution of this disease follows a well-defined sequence of events and represents a unique model to understand how the ordered acquisition of mutations drives malignancy. Abstract: Children with Down syndrome (DS) are particularly prone to haematopoietic disorders. Paediatric myeloid malignancies in DS occur at an unusually high frequency and generally follow a well-defined stepwise clinical evolution. First, the acquisition of mutations in the GATA1 transcription factor gives rise to a transient myeloproliferative disorder (TMD) in DS newborns. While this condition spontaneously resolves in most cases, some clones can acquire additional mutations, which trigger myeloid leukaemia of Down syndrome (ML-DS). These secondary mutations are predominantly found in chromatin and epigenetic regulators—such as cohesin, CTCF or EZH2—and Citation: de Castro, C.P.M.; Cadefau, in signalling mediators of the JAK/STAT and RAS pathways. -
Adult Acute Myeloid Leukemia with Trisomy 11 As the Sole Abnormality
Letters to the Editor 2254 Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2 Leukemia (2016) 30, 2254–2258; doi:10.1038/leu.2016.196 sequencing approach at the DNA level were also analyzed at the RNA level by visual inspection of the BAM files. The clinical characteristics and outcomes of 23 patients with Trisomy of chromosome 11 (+11) is the second most common sole +11 are summarized in Table 1. The patients were isolated trisomy in acute myeloid leukemia (AML) patients.1 The presence of +11 is associated with intermediate2,3 or poor 4–6 Table 1. Pretreatment clinical and molecular characteristics and patient outcomes. Whereas the clinical characteristics of solitary outcome of patients with acute myeloid leukemia (AML) and sole +11 +11 have been well established,4–6 relatively little is known about the mutational landscape of sole +11 AML in the age of next- Characteristica Sole +11 AML (n = 23) generation sequencing techniques that allow examination of multiple genes relevant to AML pathogenesis.6 So far, the most Age, years Median 71 common molecular feature in AML with isolated +11 is the – presence of a partial tandem duplication of the MLL (KMT2A) gene Range 25 84 (MLL-PTD), which is detectable in up to 90% of patients.7 Age group, n (%) Furthermore, a frequent co-occurrence of the FLT3 internal o60 years 18 (78) tandem duplication (FLT3-ITD) with MLL-PTD has been reported.8 ⩾ 60 years 5 (22) The aim of our study was to better characterize the mutational Female sex, n (%) 5 (22) landscape of adult AML patients with sole +11. -
ABC of Clinical Genetics CHROMOSOMAL DISORDERS II
ABC of Clinical Genetics CHROMOSOMAL DISORDERS II BMJ: first published as 10.1136/bmj.298.6676.813 on 25 March 1989. Downloaded from Helen M Kingston Developmental delay in Chromosomal abnormalities are generally associated with multiple child with deletion of congenital malformations and mental retardation. Children with more than chromosome 13. one physical abnormality, particularly ifretarded, should therefore undergo chromosomal analysis as part of their investigation. Chromosomal disorders are incurable but can be reliably detected by prenatal diagnostic techniques. Amniocentesis or chorionic villus sampling should be offered to women whose pregnancies are at increased risk-namely, women in their mid to late thirties, couples with an affected child, and couples in whom one partner carries a balanced translocation. Unfortunately, when there is no history of previous abnormality the risk in many affected pregnancies cannot be predicted beforehand. Autosomal abnormalities Parents Non-dysjunction Trisomy 21 (Down's syndrome) Down's syndrome is the commonest autosomal Gametes trisomy, the incidence in liveborn infants being one in 650, although more than half of conceptions with trisomy 21 do not survive to term. Affected children have a characteristic Offspring facial appearance, are mentally retarded, and Trisomy 21 often die young. They may have associated Non-dysjunction of chromosome 21 leading to Down's syndrome. congenital heart disease and are at increased risk recurrent for infections, atlantoaxial instability, http://www.bmj.com/ -- All chromosomal abnormalities at and acute leukaemia. They are often happy and 100 - ainniocentesis ---- Downl's syndrome at amniocentesis Risk for trisomy 21 in liveborn infants affectionate children who are easy to manage. -
Interaction of Acetylcholinesterase with Neurexin-1Β Regulates
Xiang et al. Molecular Brain 2014, 7:15 http://www.molecularbrain.com/content/7/1/15 RESEARCH Open Access Interaction of Acetylcholinesterase with Neurexin-1β regulates Glutamatergic Synaptic stability in Hippocampal neurons Yun-Yan Xiang1,2†, Haiheng Dong3†, Burton B Yang4, John F MacDonald1,2 and Wei-Yang Lu1,2,3,5* Abstract Background: Excess expression of acetylcholinesterase (AChE) in the cortex and hippocampus causes a decrease in the number of glutamatergic synapses and alters the expression of neurexin and neuroligin, trans-synaptic proteins that control synaptic stability. The molecular sequence and three-dimensional structure of AChE are homologous to the corresponding aspects of the ectodomain of neuroligin. This study investigated whether excess AChE interacts physically with neurexin to destabilize glutamatergic synapses. Results: The results showed that AChE clusters colocalized with neurexin assemblies in the neurites of hippocampal neurons and that AChE co-immunoprecipitated with neurexin from the lysate of these neurons. Moreover, when expressed in human embryonic kidney 293 cells, N-glycosylated AChE co-immunoprecipitated with non-O–glycosylated neurexin-1β,withN-glycosylation of the AChE being required for this co-precipitation to occur. Increasing extracellular AChE decreased the association of neurexin with neuroligin and inhibited neuroligin-induced synaptogenesis. The number and activity of excitatory synapses in cultured hippocampal neurons were reduced by extracellular catalytically inactive AChE. Conclusions: Excessive glycosylated AChE could competitively disrupt a subset of the neurexin–neuroligin junctions consequently impairing the integrity of glutamatergic synapses. This might serve a molecular mechanism of excessive AChE induced neurodegeneration. Keywords: Protein interaction, Glycosylation, Neurodegeneration, Synaptic apoptosis Introduction globular monomers and dimers of AChE-S. -
Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Down Syndrome
COMMON TYPES OF CHROMOSOME ABNORMALITIES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA A. Trisomy: instead of having the normal two copies of each chromosome, an individual has three of a particular chromosome. Which chromosome is trisomic determines the type and severity of the disorder. Down syndrome or Trisomy 21, is the most common trisomy, occurring in 1 per 800 births (about 3,400) a year in the United States. It is one of the most common genetic birth defects. According to the National Down Syndrome Society, there are more than 400,000 individuals with Down syndrome in the United States. Patients with Down syndrome have three copies of their 21 chromosomes instead of the normal two. The major clinical features of Down syndrome patients include low muscle tone, small stature, an upward slant to the eyes, a single deep crease across the center of the palm, mental retardation, and physical abnormalities, including heart and intestinal defects, and increased risk of leukemia. Every person with Down syndrome is a unique individual and may possess these characteristics to different degrees. Down syndrome patients Karyotype of a male patient with trisomy 21 What are the causes of Down syndrome? • 95% of all Down syndrome patients have a trisomy due to nondisjunction before fertilization • 1-2% have a mosaic karyotype due to nondisjunction after fertilization • 3-4% are due to a translocation 1. Nondisjunction refers to the failure of chromosomes to separate during cell division in the formation of the egg, sperm, or the fetus, causing an abnormal number of chromosomes. As a result, the baby may have an extra chromosome (trisomy). -
Acetylcholinesterase — New Roles for Gate a Relatively Long Distance to Reach the Active Site, Ache Is One of the Fastest an Old Actor Enzymes14
PERSPECTIVES be answered regarding AChE catalysis; for OPINION example, the mechanism behind the extremely fast turnover rate of the enzyme. Despite the fact that the substrate has to navi- Acetylcholinesterase — new roles for gate a relatively long distance to reach the active site, AChE is one of the fastest an old actor enzymes14. One theory to explain this phe- nomenon has to do with the unusually strong electric field of AChE. It has been argued that Hermona Soreq and Shlomo Seidman this field assists catalysis by attracting the cationic substrate and expelling the anionic The discovery of the first neurotransmitter — understanding of AChE functions beyond the acetate product15. Site-directed mutagenesis, acetylcholine — was soon followed by the classical view and suggest the molecular basis however, has indicated that reducing the elec- discovery of its hydrolysing enzyme, for its functional heterogeneity. tric field has no effect on catalysis16.However, acetylcholinesterase. The role of the same approach has indicated an effect on acetylcholinesterase in terminating From early to recent discoveries the rate of association of fasciculin, a peptide acetylcholine-mediated neurotransmission The unique biochemical properties and phys- that can inhibit AChE17. made it the focus of intense research for iological significance of AChE make it an much of the past century. But the complexity interesting target for detailed structure–func- of acetylcholinesterase gene regulation and tion analysis. AChE-coding sequences have recent evidence for some of the long- been cloned so far from a range of evolution- a Peripheral Choline binding site suspected ‘non-classical’ actions of this arily diverse vertebrate and invertebrate binding enzyme have more recently driven a species that include insects, nematodes, fish, site profound revolution in acetylcholinesterase reptiles, birds and several mammals, among Active site research. -
Cytogenetics, Chromosomal Genetics
Cytogenetics Chromosomal Genetics Sophie Dahoun Service de Génétique Médicale, HUG Geneva, Switzerland [email protected] Training Course in Sexual and Reproductive Health Research Geneva 2010 Cytogenetics is the branch of genetics that correlates the structure, number, and behaviour of chromosomes with heredity and diseases Conventional cytogenetics Molecular cytogenetics Molecular Biology I. Karyotype Definition Chromosomal Banding Resolution limits Nomenclature The metaphasic chromosome telomeres p arm q arm G-banded Human Karyotype Tjio & Levan 1956 Karyotype: The characterization of the chromosomal complement of an individual's cell, including number, form, and size of the chromosomes. A photomicrograph of chromosomes arranged according to a standard classification. A chromosome banding pattern is comprised of alternating light and dark stripes, or bands, that appear along its length after being stained with a dye. A unique banding pattern is used to identify each chromosome Chromosome banding techniques and staining Giemsa has become the most commonly used stain in cytogenetic analysis. Most G-banding techniques require pretreating the chromosomes with a proteolytic enzyme such as trypsin. G- banding preferentially stains the regions of DNA that are rich in adenine and thymine. R-banding involves pretreating cells with a hot salt solution that denatures DNA that is rich in adenine and thymine. The chromosomes are then stained with Giemsa. C-banding stains areas of heterochromatin, which are tightly packed and contain -
Neurexin–Neuroligin Signaling in Synapse Development Ann Marie Craig and Yunhee Kang
Neurexin–neuroligin signaling in synapse development Ann Marie Craig and Yunhee Kang Neurexins and neuroligins are emerging as central organizing and knockdown of neuroligins in culture led to the idea molecules for excitatory glutamatergic and inhibitory that these molecules control the balance of GABAergic GABAergic synapses in mammalian brain. They function as cell and glutamatergic inputs [4,5]. We focus our discussion adhesion molecules, bridging the synaptic cleft. Remarkably, here on studies from the past two years that address how each partner can trigger formation of a hemisynapse: alternative splicing in both neurexin and neuroligin tran- neuroligins trigger presynaptic differentiation and neurexins scripts regulates their function. We also discuss initial trigger postsynaptic differentiation. Recent protein interaction results from studies of knockout mice and disease-linked assays and cell culture studies indicate a selectivity of function mutations. conferred by alternative splicing in both partners. An insert at site 4 of b-neurexins selectively promotes GABAergic synaptic Structure of neurexins and neuroligins function, whereas an insert at site B of neuroligin 1 selectively There are three neurexin genes in mammals, each of promotes glutamatergic synaptic function. Initial knockdown which has both an upstream promoter that is used to and knockout studies indicate that neurexins and neuroligins generate the larger a-neurexins and a downstream pro- have an essential role in synaptic transmission, particularly at moter that is used to generate the b-neurexins (Figure 1) GABAergic synapses, but further studies are needed to assess [6]. Alternative splicing at five sites and N- and O-gly- the in vivo functions of these complex protein families. -
Neuroligin 3 (Nlgn3) Knockout Rat
Genetically engineered models (GEMS) Neuroligin 3 (Nlgn3) knockout rat Model Neuroligin 3 (Nlgn3) knockout rat Strain HsdSage:SD- Nlgn3tm1sage Location U.S. Availability Cryopreserved Characteristics/husbandry Research use + This model was created in collaboration with Autism Speaks + Autism and is currently undergoing phenotypic characterization by + Asperger’s syndrome Dr. Richard Paylor at Baylor College of Medicine + Synaptic plasticity + Preliminary results suggest that Nlgn3 knockout rats are less anxious and exhibit decreased juvenile play, deficits in Origin sensorimotor gating and increased perseverative behaviors The Neuroligin 3 (Nlgn3) KO rat model was originally created + Homozygous knockout rats exhibit complete loss of target at SAGE Labs, Inc. in St. Louis, MO and distributed out of the protein as demonstrated by Western blot Boyertown, PA facility. The line continues to be maintained through the original SAGE Labs animal inventory acquired by + Mutations in Nlgn3 have been associated with autism and Asperger’s syndrome Envigo. + Nlgn3 is a member of the broader neuroligins, neuronal cell surface proteins thought to play a role in synaptic plasticity Description This model contains a biallelic deletion of the neuroligin 3 gene + Background strain: Sprague Dawley (Nlgn3). Mutations in Nlgn3 have been linked with autism and Asperger’s syndrome. This model is useful for understanding Zygosity genotype the role of neuroligins in the development of autism spectrum disorders. + Cryopreserved as heterozygous embryos Neuroligins -
Paternally Inherited Trisomy at D21S11 and Mutation at DXS10135 Microsatellite Marker in a Case of Fetus Paternity Establishment
Egyptian Journal of Forensic Sciences (2015) xxx, xxx–xxx HOSTED BY Contents lists available at ScienceDirect Egyptian Journal of Forensic Sciences journal homepage: http://www.journals.elsevier.com/egyptian-journal-of-forensic-sciences CASE REPORT Paternally inherited trisomy at D21S11 and mutation at DXS10135 microsatellite marker in a case of fetus paternity establishment Pankaj Shrivastava a,*, Toshi Jain a,b, Sonia Kakkar c, Veena Ben Trivedi a a DNA Fingerprinting Unit, State Forensic Science Laboratory, Department of Home (Police), Govt. of Madhya Pradesh, Sagar 470001, MP, India b School of Studies in Microbiology, Jiwaji University, Gwalior, MP, India c Deptt of Forensic Medicine, PGIMER, Chandigarh, India Received 3 June 2015; revised 29 July 2015; accepted 6 September 2015 KEYWORDS Abstract The case of establishment of paternity of an aborted fetus was examined with 15 auto- DNA profiling; somal STR markers. The genotype of the fetus was X at amelogenin marker and showed inheritance D21S11; of both the alleles of father at D21S11 marker, thus displaying unusual tri-allelic pattern. The cases DXS10135; where mutation in any of biparental autosomal STR markers is observed, the use of additional STR X-STR; marker system is recommended. On testing all the three samples with 12 X-STR markers, all the Trisomy; maternal and paternal alleles were accounted in the female fetus except at DXS10135 marker. Mutation The genotypes of mother, fetus and father at DXS10135 were 20, 22; 20, 20 and 21, which confirmed mutation of the paternal allele in the female fetus. The paternal allele contracted from 21 to 20. The allele peak heights of D21S11 and DXS10135 markers were also examined to rule out the possibility of any false allele. -
©Ferrata Storti Foundation
Malignant Lymphomas original paper haematologica 2001; 86:71-77 Splenic marginal zone B-cell http://www.haematologica.it/2001_01/0071.htm lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q FRANCESC SOLÉ,* MARTA SALIDO,* BLANCA ESPINET,* *Laboratori de Citologia Hematològica, Laboratori de Referència JUAN LUÍS GARCIA,° JOSÉ ANGEL MARTINEZ CLIMENT,# ISABEL de Catalunya, Departament de Patologia, Hospital del Mar, IMAS, GRANADA,@ JESÚS Mª HERNÁNDEZ,° ISABEL BENET,# MIGUEL IMIM, Barcelona; Escola de Citologia Hematològica Soledad ANGEL PIRIS,^ MANUELA MOLLEJO,§ PEDRO MARTINEZ,§ Woessner-IMAS; °Servicio de Hematología, Hospital Universitario TERESA VALLESPÍ,** ALICIA DOMINGO,°° SERGI SERRANO,* Centro de Investigación del Cáncer, Universidad de Salamanca- CSIC; #Servicio de Hematología y Oncología Médica, Hospital Clíni- SOLEDAD WOESSNER,* LOURDES FLORENSA* co Universitario de Valencia; @Servei d'Hematologia Hospital Ger- mans Trias i Pujol, Badalona; ^Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas Carlos III, Madrid; §Servicio de Anatomia Patológica, Complejo Hospitalario de Tole- Correspondence: Francesc Solé, M.D., Laboratori de Citologia Hema- do; **Servicio de Hematología. Hospital Universitari Vall d'He- tològica, Laboratori de Referència de Catalunya, Departament de brón, Barcelona; °°Servicio de Hematología, Laboratorio de Patologia, Hospital del Mar, Passeig Maritim, 25-29, 08003 Barcelona, Spain. Phone: international +34-93-2211010 ext.1073 Fax: interna- Citología Hematológica, Ciudad Sanitaria y Universitaria de Bell- tional +34-93-2212920 - E-mail: [email protected] vitge, Hospital Princeps d’Espanya, Spain Background and Objectives. Splenic marginal zone B-cell plenic marginal zone B-cell lymphoma (SMZBCL) is lymphoma (SMZBCL) has clinical, immunophenotypic and a recognized entity for which the clinical, morpho- histologic features distinct from other B-cell malignancies, logic, immunophenotypic and histologic character- but few chromosome studies have been previously report- S 1-3 ed.